Oncolytics Biotech Inc. (TSX:ONC)
Canada · Delayed Price · Currency is CAD 1.700
+0.170 (11.11%)
Jul 16, 2025, 4:00 PM EDT
Oncolytics Biotech Employees
Oncolytics Biotech had 28 employees as of December 31, 2024. The number of employees decreased by 1 or -3.45% compared to the previous year.
Employees
28
Change
-1
Growth
-3.45%
Revenue / Employee
n/a
Profits / Employee
-1.13M CAD
Market Cap
147.80M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28 | -1 | -3.45% |
| Dec 31, 2022 | 29 | 3 | 11.54% |
| Dec 31, 2021 | 26 | 1 | 4.00% |
| Dec 31, 2020 | 25 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Green Thumb Industries | 4,800 |
| Sienna Senior Living | 12,263 |
| dentalcorp Holdings | 10,200 |
| WELL Health Technologies | 1,507 |
| Curaleaf Holdings | 5,519 |
| Trulieve Cannabis | 6,000 |
| Extendicare | 23,000 |
| Cronos Group | 459 |
Oncolytics Biotech News
- 6 days ago - Oncolytics Biotech® to Host Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal Cancers - PRNewsWire
- 8 days ago - Oncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies - PRNewsWire
- 16 days ago - Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy - PRNewsWire
- 5 weeks ago - Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs - PRNewsWire
- 7 weeks ago - Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities - PRNewsWire
- 2 months ago - Oncolytics Biotech Inc. (ONCY) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Oncolytics Biotech® Reports First Quarter Financial Results and Highlights Clinical Momentum - PRNewsWire
- 2 months ago - Oncolytics Biotech Q1 2025 Earnings Preview - Seeking Alpha